ABBV vs TSM: Which Is the Better Buy?

Side-by-side comparison of AbbVie Inc. and Taiwan Semiconductor Manufacturing Company Limited — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C High Quality
VS
Taiwan Semiconductor Manufacturing Company Limited · Technology
$365.90
-3.8% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
ABBV has more upside to fair value (+4.5%). ABBV trades at a lower forward P/E (14.9x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric ABBV TSM
Current Price $208.05 $365.90
Fair Value Estimate $217.50 $352.00
Upside to Fair Value +4.5% -3.8%
Market Cap $367.9B $1,897.7B
Forward P/E 14.9x 26.0x
EV / EBITDA 16.7x 18.1x
Price / Sales 6.1x 13.3x
Price / FCF 20.9x 54.0x
Revenue Growth YoY +8.6% +33.0%
Gross Margin 83.7% 59.9%
Operating Margin 34.7% 50.8%
Return on Equity -129.24% 35.1%
Dividend Yield 3.2% 1.05%
FCF Yield 4.78% 1.85%
Analyst Consensus Buy Strong Buy
Investment Thesis
ABBV — AbbVie Inc.
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
TSM — Taiwan Semiconductor Manufacturing Company Limited
TSMC remains the single most critical company in the global semiconductor supply chain, manufacturing virtually every leading-edge AI chip for NVIDIA, Apple, AMD, and the hyperscalers. The company delivered exceptional 2025 results with 33% revenue growth and 50% net income growth, driven by HPC surging to 55% of Q4 revenue. At the 3nm node, TSMC maintains production yields of 70-80% versus Samsu…
Accumulation Zones
Metric ABBV TSM
Zone Low $163.13 $265.00
Zone High $184.88 $310.00
In Buy Zone? No No
← ABBV Research    TSM Research →    All Research